Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Hashimoto

Showing results (771-780 of 1,929) with videos related to

Pageof 193
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Inhibition of cell growth in culture by quinonesH Kamei, T Koide, T Kojima, et al.
Masui. the Japanese Journal of Anesthesiology|July 1, 1990
[Changes in arterial oxygen tension during and after enflurane or halothane anesthesia as well as epidural analgesia]K Hoshi, T Shima, K Andoh, et al.
European Journal of Pharmacology|April 5, 2000
Inhibitory effect of novel oral hypoglycemic agent nateglinide (AY4166) on peptide transporters PEPT1 and PEPT2T Terada, K Sawada, H Saito, et al.
British Journal of Pharmacology|December 1, 1999
Effects of glibenclamide on glycylsarcosine transport by the rat peptide transporters PEPT1 and PEPT2K Sawada, T Terada, H Saito, et al.
Rinsho Shinkeigaku = Clinical Neurology|February 24, 2001
[A case of Ondine curse associated with a medullary tumor]M Nakajima, K Katsura, Y Hashimoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|February 24, 2001
[Clinical role of cell cycle regulators in androgen-dependent cancer cell growth]Y Hashimoto, H Akita, A Iizuka, et al.
Biological & Pharmaceutical Bulletin|January 6, 2001
Enhancing effect of tumor promoters, phorbol esters and teleocidins on nuclear receptor-mediated transcriptionH Fukasawa, M Yamaguchi, Y Hashimoto, et al.
FEMS Microbiology Letters|April 8, 2000
Amino acid substitutions in the VanS sensor of the VanA-type vancomycin-resistant Enterococcus strains result in high-level vancomycin resistance and low-level teicoplanin resistanceY Hashimoto, K Tanimoto, Y Ozawa, et al.
Annals of the Rheumatic Diseases|October 1, 1975
Fc-rosette inhibition by hypocomplementaemic systemic lupus erythematosus seraT Morito, K Tanimoto, Y Hashimoto, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1994
Decrease in lymphokine-activated killer sensitivity of a human renal-cell carcinoma cell line after cytokine treatmentM Yanase, T Tsukamoto, Y Kumamoto, et al.
Pageof 193

Showing results (771-780 of 1,929) with videos related to

Sort By:
Pageof 193
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Inhibition of cell growth in culture by quinonesH Kamei, T Koide, T Kojima, et al.
Masui. the Japanese Journal of Anesthesiology|July 1, 1990
[Changes in arterial oxygen tension during and after enflurane or halothane anesthesia as well as epidural analgesia]K Hoshi, T Shima, K Andoh, et al.
European Journal of Pharmacology|April 5, 2000
Inhibitory effect of novel oral hypoglycemic agent nateglinide (AY4166) on peptide transporters PEPT1 and PEPT2T Terada, K Sawada, H Saito, et al.
British Journal of Pharmacology|December 1, 1999
Effects of glibenclamide on glycylsarcosine transport by the rat peptide transporters PEPT1 and PEPT2K Sawada, T Terada, H Saito, et al.
Rinsho Shinkeigaku = Clinical Neurology|February 24, 2001
[A case of Ondine curse associated with a medullary tumor]M Nakajima, K Katsura, Y Hashimoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|February 24, 2001
[Clinical role of cell cycle regulators in androgen-dependent cancer cell growth]Y Hashimoto, H Akita, A Iizuka, et al.
Biological & Pharmaceutical Bulletin|January 6, 2001
Enhancing effect of tumor promoters, phorbol esters and teleocidins on nuclear receptor-mediated transcriptionH Fukasawa, M Yamaguchi, Y Hashimoto, et al.
FEMS Microbiology Letters|April 8, 2000
Amino acid substitutions in the VanS sensor of the VanA-type vancomycin-resistant Enterococcus strains result in high-level vancomycin resistance and low-level teicoplanin resistanceY Hashimoto, K Tanimoto, Y Ozawa, et al.
Annals of the Rheumatic Diseases|October 1, 1975
Fc-rosette inhibition by hypocomplementaemic systemic lupus erythematosus seraT Morito, K Tanimoto, Y Hashimoto, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1994
Decrease in lymphokine-activated killer sensitivity of a human renal-cell carcinoma cell line after cytokine treatmentM Yanase, T Tsukamoto, Y Kumamoto, et al.
Pageof 193